The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II randomized trial of durvalumab (D) versus physician’s choice chemotherapy (PCC) in patients (pts) with recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3).
 
David Shao Peng Tan
Stock and Other Ownership Interests - Asian Microbiome Library
Honoraria - AstraZeneca; Bayer; Eisai; Foundation Medicine; Merck; MSD; Roche; Turbine
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Merck; MSD; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck; Novartis; Roche
 
Chel Hun Choi
No Relationships to Disclose
 
Natalie Ngoi
No Relationships to Disclose
 
Haoyang Sun
No Relationships to Disclose
 
Valerie Heong
Honoraria - AstraZeneca; DKSH; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; DKSH; Merck; Novartis; Pfizer
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Wen Yee Chay
No Relationships to Disclose
 
Hee Seung Kim
No Relationships to Disclose
 
Yi Wan Lim
No Relationships to Disclose
 
Geraldine Goss
Honoraria - Merck
Consulting or Advisory Role - AstraZeneca
 
Jeffrey C. Goh
Stock and Other Ownership Interests - ICON Cancer Care; Immutep
Honoraria - Ipsen; MSD Oncology
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen Oncology; MSD
Speakers' Bureau - AstraZeneca/MedImmune; BMS; Ipsen; Janssen; MSD Oncology
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Vilianty Luo
Employment - Medtronic
Stock and Other Ownership Interests - Medtronic
Travel, Accommodations, Expenses - Medtronic
 
Bee Choo Tai
Patents, Royalties, Other Intellectual Property - co-author of two books, and am paid royalty by Wiley-Blackwell
 
Diana Lim
No Relationships to Disclose
 
Nivashini Kaliaperumal
No Relationships to Disclose
 
Veonice Bijin AU
No Relationships to Disclose
 
John Connolly
Leadership - 3T BioSciences; Dispatch Therapeutics; kiik Therapeutics
Stock and Other Ownership Interests - 3T BioSciences; Tessa Therapeutics
Consulting or Advisory Role - Bit.Bio; Hummingbird
Research Funding - Bit.Bio; Janssen Biotech
Patents, Royalties, Other Intellectual Property - Tessa Licence
Travel, Accommodations, Expenses - Bit Bio – on reimbursement basic
 
Jae-Weon Kim
No Relationships to Disclose
 
Michael Friedlander
Honoraria - AstraZeneca; GlaxoSmithKline; Lilly; MSD; Novartis; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - ACT Genomics; AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Kidong Kim
Stock and Other Ownership Interests - AIDOT
Honoraria - AstraZeneca/MedImmune; Merck; Pfizer; SK Chemicals
Consulting or Advisory Role - NOUL
Research Funding - Johnson & Johnson/Janssen